A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Scared of needles but intrigued by injectable drugs that help manage blood sugar levels? You'll be happy to know Eli Lilly ...

Novo Nordisk’s Vikrant Shrotriya on accelerating Wegovy’s launch, pricing strategy, and building long-term obesity care ...

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their GLP-1 products. Lilly markets its dual GIP and GLP-1 receptor agonist, ...

SMITHTOWN, NY, UNITED STATES, April 4, 2025 /EINPresswire / -- The rise of weight-loss medications like Ozempic, Wegovy, and Mounjaro has transformed bodies-and unexpectedly, faces. As thousands ...

You can learn more about how these drugs compare in the “Effectiveness of Ozempic vs. Trulicity” section. If your blood sugar isn’t well managed with one of these drugs, your doctor is more ...

Ozempic improved maximum walking distance by 13% in peripheral artery disease patients over 52 weeks. Rybelsus reduced the risk of major cardiovascular events by 14% in high-risk patients.

Keep in mind that weight loss is an off-label use for Ozempic. To learn more about the uses for each drug, see the “Uses of Saxenda vs. Ozempic” section. Keep reading for details about the ...

As in my article "AbbVie vs. Sanofi: Which Is the Better Investment ... and psoriatic arthritis treatment market. They are Ozempic, Wegovy, Rybelsus, NovoRapid, and NovoSeven, whose combined ...

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...